Protocol for a randomized controlled trial of electroacupuncture in the management of patients with axial spondyloarthritis in Singapore (E‐AcuSpA)-Reference-Cited by-同舟云学术

Protocol for a randomized controlled trial of electroacupuncture in the management of patients with axial spondyloarthritis in Singapore (E‐AcuSpA)

Published:2021-12 Issue:2 Volume:1 Page:104-114
ISSN:2767-1429
Container-title:Rheumatology & Autoimmunity
language:en
Short-container-title:Rheumatology & Autoimmunity

Author:

Fong Warren¹²³,Kwan Yu Heng⁴⁵⁶,Quek Su‐An⁷,Lim Ader⁷,Wong Chiah Yuen⁷,Chua Shin Yoong⁷,Tan Hui Chin⁷,Eng Clara⁷,Tan Choy Tip⁷,Dong Bao Qiang⁸,Huang Youyi⁴,Tan Chuen Seng⁹,Tai Bee Choo⁹,Woon Ting Hui¹,Phang Jie Kie¹,Koh Hwee Ling⁶,Leung Ying Ying¹²,Thumboo Julian¹⁵,Østbye Truls⁵

Affiliation:

1. Department of Rheumatology and Immunology Singapore General Hospital Singapore Singapore

2. Duke‐NUS Medical School Singapore Singapore

3. Department of Medicine, Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore

4. Internal Medicine Residency, SingHealth Singapore Singapore

5. Programme in Health Services and Systems Research Duke‐NUS Medical School Singapore Singapore

6. Department of Pharmacy National University of Singapore Singapore Singapore

7. Singapore Thong Chai Medical Institution Singapore Singapore

8. Acupuncture and Tuina College Liaoning University of Traditional Chinese Medicine Shenyang Liaoning P.R. China

9. Saw Swee Hock School of Public Health National University of Singapore Singapore Singapore

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rai2.12019

Reference57 articles.

1. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

2. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

3. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

4. Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1

5. Ankylosing Spondylitis and Axial Spondyloarthritis